secwatch.observer — SEC 8-K summary
======================================

Issuer:     PTC THERAPEUTICS, INC. (PTCT)
CIK:        0001070081
Form:       8-K
Filed at:   2026-06-09T21:15:22+00:00
Accession:  0001104659-26-071916
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Alethia Young resigns from PTC board, stays as consultant at $4,167/month
--------------------------------------------------------------------------------

- Alethia Young resigned from the Board effective June 8, 2026; no disagreement cited.
- She entered a consulting agreement through June 8, 2027 for monthly fee of $4,166.67.
- Outstanding stock options and RSUs will continue to vest during consulting term.
- Exercisability of options extends to three years after termination (max 10 years from grant).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070081/000110465926071916/0001104659-26-071916-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070081/000110465926071916/tmb-20260608x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-071916

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer